American Century Companies Inc. Has $1.61 Million Stock Holdings in Maximus, Inc. (NYSE:MMS)

American Century Companies Inc. boosted its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 63.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,547 shares of the health services provider's stock after buying an additional 8,332 shares during the period. American Century Companies Inc.'s holdings in Maximus were worth $1,608,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of MMS. Geode Capital Management LLC raised its stake in Maximus by 1.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock valued at $142,109,000 after purchasing an additional 21,532 shares during the last quarter. Van Berkom & Associates Inc. increased its holdings in shares of Maximus by 8.5% during the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock worth $93,792,000 after purchasing an additional 98,264 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Maximus by 7.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after buying an additional 71,598 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Maximus by 2.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock valued at $54,748,000 after buying an additional 16,772 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in shares of Maximus by 8.2% in the fourth quarter. Bank of New York Mellon Corp now owns 570,740 shares of the health services provider's stock valued at $42,606,000 after buying an additional 43,421 shares during the period. 97.21% of the stock is owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a report on Thursday, January 2nd. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Maximus Price Performance

NYSE MMS traded down $0.67 on Tuesday, reaching $68.07. The company's stock had a trading volume of 12,654 shares, compared to its average volume of 546,805. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a market cap of $3.85 billion, a PE ratio of 14.68 and a beta of 0.68. The business has a 50-day moving average price of $67.75 and a 200 day moving average price of $75.87.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.76%. Maximus's dividend payout ratio is 25.81%.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.